Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer

Business Wire··Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Acadia Pharmaceuticals has appointed Carl Segerstrom as Chief People Officer, effective July 6. Segerstrom will lead the company's global people and culture strategy and serve on the executive leadership team. He brings more than 25 years of global human resources leadership experience, most recently as Senior Vice President of Human Resources at Merck's Human Health Division, supporting a $50+ billion business across 80 countries. His background includes roles as Chief Talent Officer at Merck and HR leadership positions at Pharmacia, Schering-Plough, and Pfizer. Acadia is focused on advancing therapies for neurological and rare diseases, with a commercial portfolio that includes the first and only FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome.

Impact on assets 4

Biotech & Genomic Medicine▲
ACADIA Pharmaceuticals Inc
ACAD
± Mixedrelevance

Appointment of a new Chief People Officer is a routine corporate change; no clear impact on business performance.

Critical Materials & Supply Chain▲